Medications for Hematochezia
Initial Resuscitation and Hemodynamic Support
For patients presenting with hematochezia, immediately initiate intravenous fluid resuscitation and blood product transfusion as needed to maintain hemoglobin >7 g/dL and mean arterial pressure >65 mmHg. 1
- Obtain complete blood count, coagulation studies (PT/INR, PTT), blood type and cross-match for potential transfusion 1
- Correct coagulopathy with appropriate blood products if present 1
- In patients on oral anticoagulants with major bleeding, administer reversal agents: vitamin K 5-10 mg IV for warfarin, idarucizumab for dabigatran, or andexanet alfa for apixaban/rivaroxaban 1, 2
Proton Pump Inhibitor Therapy
Administer high-dose intravenous omeprazole (80 mg bolus followed by 8 mg/hour continuous infusion for 72 hours) if upper GI bleeding is suspected or confirmed, as this reduces rebleeding rates, transfusion requirements, and hospital stay. 1, 3
- Start PPI therapy immediately, even before endoscopy, as 14% of hematochezia cases originate from upper GI sources (most commonly duodenal ulcers) 1, 4
- The rationale is that pH >6 is necessary for platelet aggregation and clot stability, while clot lysis occurs when pH falls below 6 1, 3
- After 72-hour IV infusion, transition to oral PPI therapy for 6-8 weeks to allow mucosal healing 3
- H2 receptor antagonists are NOT recommended as they do not reliably increase gastric pH to 6 1
Vasoactive Medications for Variceal Bleeding
If anorectal varices or portal hypertension is suspected (based on history of cirrhosis), consider terlipressin or octreotide to reduce splanchnic blood flow and portal pressure. 1
- Terlipressin is the most evidence-based vasoactive agent for variceal bleeding 1
- Octreotide is an acceptable alternative with a better safety profile than vasopressin 1
- Temporarily suspend non-selective beta-blockers during acute bleeding episodes 1
Antibiotic Prophylaxis
Administer a short course of prophylactic antibiotics in patients with bleeding anorectal varices and underlying cirrhosis. 1
- This is a strong recommendation based on moderate quality evidence for reducing infection-related complications 1
Pre-Endoscopy Adjunctive Therapy
Administer erythromycin before endoscopy to enhance gastric visualization by promoting gastric emptying. 3
Medications to AVOID or DISCONTINUE
- Stop all antiplatelet agents (aspirin, clopidogrel) in patients with major bleeding 1
- Discontinue NSAIDs immediately as they are a common cause of peptic ulcer bleeding 1
- Do NOT use somatostatin routinely despite theoretical benefits, as evidence quality is insufficient 1
- Do NOT use tranexamic acid routinely, as further studies are needed despite some meta-analysis data suggesting benefit 1
Critical Clinical Pearls
- Never delay endoscopic intervention while relying solely on PPI therapy - medications complement but do not replace endoscopy 3
- Upper GI bleeding presenting as hematochezia carries worse prognosis with higher transfusion requirements (5.4 vs 4.0 units), increased need for surgery (11.7% vs 5.7%), and higher mortality (13.6% vs 7.5%) compared to melena presentation 4
- Cirrhosis independently predicts upper GI source of bleeding (OR 3.47) in hematochezia patients, with 30-day mortality of 17.5% versus 4.1% in non-cirrhotics 5